No abstract available
MeSH terms
-
Canada / epidemiology
-
Canagliflozin / pharmacology
-
Canagliflozin / therapeutic use
-
Consensus*
-
Diabetes Mellitus, Type 2 / diagnosis
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / epidemiology
-
Disease Management*
-
Health Policy*
-
Humans
-
Hypoglycemic Agents / pharmacology
-
Hypoglycemic Agents / therapeutic use*
-
Practice Guidelines as Topic / standards*
-
Sodium-Glucose Transporter 2
-
Sodium-Glucose Transporter 2 Inhibitors
Substances
-
Hypoglycemic Agents
-
SLC5A2 protein, human
-
Sodium-Glucose Transporter 2
-
Sodium-Glucose Transporter 2 Inhibitors
-
Canagliflozin